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The small ubiquitin-like modifier (SUMO) can 
be covalently attached to a large number of   
proteins through formation of isopeptide bonds 
with specific lysine residues of target proteins 
(Müller et al., 2001; Seeler and Dejean, 2003; 
Gill,  2004).  SUMO,  like  ubiquitin  (Pickart, 
2001),  is  covalently  attached  to  substrate 
proteins via an isopeptide bond between a 
C-terminal glycine and a lysine residue in the 
substrate. A consensus SUMO acceptor site   
has been identified consisting of the sequence 
ØKXE (Ø is a large hydrophobic amino acid 
and K is the site of SUMO conjugation). A 
large number of proteins with important roles 
in many cellular processes, including gene ex-
pression, chromatin structure, signal transduc-
tion, and maintenance of the genome, have 
been found to be SUMOylated (Müller et al., 
2001; Gill, 2004). Nuclear proteins, including 
transcription factors, are a major group of pro-
teins  among  SUMOylated  proteins.  These   
include p53, c-Jun, Sp3, Elk-1, p300 histone 
acetyltransferase, HDAC (histone deacetylase), 
PML, HIPKs, and the GATA family proteins. 
SUMOylation of these proteins has not been 
generally associated with increased protein deg-
radation. Rather, SUMO modification regu-
lates protein localization, protein–protein or 
protein–DNA interactions, and/or biochemical 
activities. The consequence of SUMOylation 
on protein function is substrate specific.
SUMOylation is a dynamic process that is 
mediated by activating, conjugating, and ligating 
enzymes and is readily reversed by a family of 
SUMO-specific proteases (Li and Hochstrasser, 
1999). The enzymatic machinery that adds and 
removes SUMO is similar to, but distinct from, 
the well known ubiquitination machinery. The 
E1-activating  and  E2-conjugating  enzymes   
involved in SUMOylation are highly related   
to the ubiquitination system. However, the 
SUMO E3 ligase that promotes transfer of 
SUMO from the E2 to specific substrates and 
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Small ubiquitin-like modifier (SUMO) modification of proteins (SUMOylation) and  
deSUMOylation have emerged as important regulatory mechanisms for protein function. 
SENP1 (SUMO-specific protease) deconjugates SUMOs from modified proteins. We have 
created SENP1 knockout (KO) mice based on a Cre–loxP system. Global deletion of SENP1 
(SENP1 KO) causes anemia and embryonic lethality between embryonic day 13.5 and postnatal 
day 1, correlating with erythropoiesis defects in the fetal liver. Bone marrow transplantation 
of SENP1 KO fetal liver cells to irradiated adult recipients confers erythropoiesis defects. 
Protein analyses show that the GATA1 and GATA1-dependent genes are down-regulated in 
fetal liver of SENP1 KO mice. This down-regulation correlates with accumulation of a  
SUMOylated form of GATA1. We further show that SENP1 can directly deSUMOylate GATA1, 
regulating GATA1-dependent gene expression and erythropoiesis by in vitro assays. Moreover, 
we demonstrate that GATA1 SUMOylation alters its DNA binding, reducing its recruitment to 
the GATA1-responsive gene promoter. Collectively, we conclude that SENP1 promotes GATA1 
activation and subsequent erythropoiesis by deSUMOylating GATA1.
© 2010 Yu et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e1184 DeSUMOylation of GATA1 drives erythropoiesis | Yu et al.
(Peschle et al., 1985). Erythropoiesis takes place within the BM 
microenvironment after birth. During definitive erythropoiesis 
in fetal liver or adult BM, the committed erythroid progenitors 
first give rise to erythroid burst-forming unit (BFU-e) and then 
to erythroid CFU (CFU-e) cells, which, in turn, mature into 
enucleated erythrocytes through multiple steps.
Previous studies have demonstrated that GATA1, a mem-
ber of the GATA family consisting of six transcription factors 
(GATA1–GATA6), is essential for normal erythropoiesis. 
GATA1-deficient embryonic stem (ES) cells are able to con-
tribute to all different tissues in chimeric mice, with the excep-
tion of the mature red blood cells (Pevny et al., 1991; Weiss   
et al., 1994). Expression of GATA1 during embryogenesis   
appears after GATA2, a GATA family member involved in 
primitive hematopoiesis (Godin and Cumano, 2002; Orkin and 
Zon, 2008). However, GATA1 is highly expressed in fetal liver 
(embryonic day (E) 11–15). Consistently, GATA1-null mouse 
the SUMO-specific protease that removes SUMO from spe-
cific substrates are different from those involved in ubiquitina-
tion and deubiquitination. In contrast to the large number of 
ubiquitin E3 ligases, only three groups of SUMO E3 ligases 
have been identified (Gill, 2004): RanBP2, the PIAS proteins, 
and the polycomb group protein Pc2. Six members of the   
sentrin-specific protease (SENP) family (SENP1–3 and SENP5–
7) have been reported in the mammalian system (Gong et al., 
2000; Kim et al., 2000; Nishida et al., 2000; Best et al., 2002; 
Hang and Dasso, 2002; Kadoya et al., 2002; Zhang et al., 2002; 
Bailey and O’Hare, 2004). SENP1 is a protease that appears to 
deconjugate a large number of SUMOylated proteins (Gong   
et al., 2000). Different members of these SUMO-specific pro-
teases appear to localize in different cellular compartments, 
where they regulate protein function by modifying protein   
stability, cellular localization, and protein–protein interac-
tions (Suzuki et al., 1999; Gong et al., 2000; Kim and Iwao, 
2000; Best et al., 2002; Kadoya et al., 2002; Zhang et al., 2002; 
Bailey and O’Hare, 2004). However, the in vivo function of 
these SUMO-specific proteases is largely unknown.
Erythropoiesis is a complex multistage process that is con-
served in human, mouse, and zebrafish systems (Godin and   
Cumano, 2002; Orkin and Zon, 2008). During mouse develop-
ment, erythropoiesis first occurs within the blood islands of the 
embryos. This stage, which is termed primitive, is characterized 
by the production of nucleated red cells that express embryonic 
globins. After development of definitive hematopoietic progeni-
tors in the blood islands and the aorta-gonad-mesonephros re-
gion, erythropoiesis shifts to the liver around day 10 of gestation, 
where it remains for the majority of fetal life. This stage is char-
acterized by profound expansion of erythroid progenitors and 
expression of a definitive adult pattern of globin molecules   
Figure 1.  Generation of SENP1-flox and 
KO mice. (A) Schematic diagram for strategy to 
generate SENP1-flox mice. The targeting vector 
contains intron 3 at the 5 arm, exons 5/6 in the 
targeting region, and intron 5 at the 3 arm. The 
5 probe with NcoI digest and 3 probe with 
BamHI digest are indicated. PCR primers for WT 
(WT1 and WT2) and KO alleles (KO1 and KO2) are 
shown. (B and C) Screening of ES clones. G418-
resistant stable ES clones were obtained after 
electroporation of the SENP1 targeting vector. 
Genomic DNA from these clones were extracted 
and used for screening. Clones were first verified 
as positive for lox P1, P2, and P3 by PCR with 
primers. The positive clones with SENP1 were 
further screened by Southern blotting using the 
5 probe after NcoI digest (B) and 3 probe after 
BamHI digest (C). WT and lox alleles with  
expected sizes are indicated. Two independent 
SENP1lox/+ ES cell clones were injected into 
C57BL/6 blastocysts. Chimeras were further bred 
with C57BL/6 females for germline transmission. 
(D) Generation of SENP1+/lox and SENP1+/ mice. 
SENP1+/lox mice were mated with -actin–Cre 
mice. Tail genomic DNA was used to determine 
SENP1 deletion by PCR with KO primers adjacent 
to 5 of lox P1 (KO1) and 3 of lox P3 (KO2) to 
obtain heterozygous mice with a deletion of 
both the targeting region (the exons 5/6) and 
the Neo gene (SENP1+/). SENP1 KO mice were 
obtained by intercrossing between the heterozy-
gous (SENP1+/) male and female. Representa-
tive genotyping of +/+, +/, and / mice are 
shown with WT primers (within the exon 6 as 
indicated in A) and KO primers. (E) SENP1 dele-
tion in embryos. Deletion of SENP1 in embryos 
was confirmed by Western blotting with anti-
SENP1 antibody. Tubulin was used as a loading 
control. (F) The observed numbers of SENP1 KO 
mice during different embryonic and perinatal 
stages (E9.5–16.5, E16.5–P0, and P1–21). The 
observed and expected ratios are shown.JEM VOL. 207, June 7, 2010 
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c-Myb, and antiapoptotic protein Bcl-XL (Zon et al., 1991; 
Chiba et al., 1993; Gregory et al., 1999; Lacombe and Mayeux, 
1999). Among these factors, EpoR has been well established to 
be critical for definitive erythropoiesis in mouse fetal liver (Lin 
et al., 1996; Wu et al., 1995; Lee et al., 2001). Interestingly, the 
role of GATA1 in erythropoiesis is dose dependent. GATA1 
knockdown embryos (GATA1.05), which express only 5% 
of the WT GATA1 levels, also die between E11.5 and 12.5 
(Takahashi  et  al.,  1997).  Other  GATA1  knockdown  mice 
(GATA1 low; McDevitt et al., 1997), which express 20% of 
embryos die from severe anemia between E10.5 and 11.5   
(Fujiwara et al., 1996). GATA1 consists of three functional do-
mains: an N-terminal activation domain, the N-terminal zinc 
finger (N finger), and the C-terminal zinc finger (C finger). 
GATA1 binds to the DNA consensus sequence (A/T)GATA 
(A/G) by two zinc finger motifs (Ferreira et al., 2005). The critical 
role of GATA1 in erythropoiesis is attributed to its activity in 
driving expression of many erythropoietic genes. These genes 
include heme biosynthesis enzyme hemoglobins, erythropoi-
etic growth factor receptor EpoR and c-Kit, mitogenic factor 
Figure 2.  Erythropoietic defects in fetal liver of SENP1 KO mice. (A) Appearance of WT and SENP1 KO embryos at E16.5. Freshly dissected  
embryos without staining were photographed. Embryo with yolk sac (top) and without yolk sac (bottom) are shown. Yolk sac, placenta, and fetal liver are 
indicated. Bars, 200 µM. (B) Wet weight of fetal livers in WT and SENP1 KO embryos (n = 6 each group). Data are mean ± SEM from five fetal livers per 
group. *, P < 0.01. (C) Histology examination of WT and SENP1 KO E13.5 fetal livers by hematoxylin/eosin staining. Bars, 100 µM. (D) Number of erythro-
poietic cells per high-power field (40×) was quantified from five sections. *, P < 0.01. (E) Freshly isolated E13.5 WT or SENP1 KO fetal liver cells were incu-
bated in PharmLyse to remove mature red blood cells, and the remaining erythroid progenitor cells were doubly stained with anti-Ter119 followed by flow 
cytometry (FACS) analysis. The percentage of Ter119+ cells is shown. Data are mean ± SEM from five fetal livers per group. *, P < 0.01. (F) E13.5 fetal liver 
touch preparations and May-Giemsa staining. Arrows indicate proerythroblasts. Bars, 20 µM. (G) Quantitative RT-PCR analysis of hemoglobin (Hbb) forms 
in E13.5 WT and SENP1 KO fetal livers. 18S rRNA was used for normalization. Hbb-a1 and Hbb-b1 are adult hemoglobin, whereas Hbb-x and Hbb-y are 
the corresponding embryonic forms. Data are mean ± SEM from six embryos of each genotype. *, P < 0.01. (H) E13.5 fetal liver cells from WT and SENP1 
KO mice were used for colony forming assays of immature BFU-e, CFU-e, CFU-mk, CFU-G/M, and CFU-G or CFU-M. 104 cells were seeded as duplicates 
from WT and SENP1 KO fetal livers (n = 5 each). *, P < 0.01. Data are mean ± SEM from triplicates of two independent experiments.1186 DeSUMOylation of GATA1 drives erythropoiesis | Yu et al.
erythropoiesis; Orkin and Zon, 2008). Starting around E11 
until 1 wk after birth, the fetal liver is the major erythropoietic 
organ. Fetal liver in SENP1 KO was smaller in size (Fig. 2 A) 
and lighter in weight (Fig. 2 B). Histological examination of 
fetal liver sections revealed a marked decrease in the number 
of morphologically identifiable small-sized erythroid cells 
(erythroblasts) with condensed chromatin nucleus in SENP1 
KO fetal liver (Fig. 2, C and D [quantification]) as well as by 
FACS with erythrocyte marker Ter119 (Fig. 2 E). Although 
decreased erythropoietic islands were clearly discernable in 
SENP1 KO fetal livers, fetal liver touch preparations by May-
Giemsa staining analysis showed a disproportionate abundance 
of immature erythroblasts, such as proerythroblasts, compared 
with WT mice (Fig. 2 F).
To further determine if SENP1 KO mice display defects 
in erythropoiesis leading to anemia, hemoglobin levels in 
E13.5 fetal livers from SENP1 WT and SENP1 KO mice 
were analyzed by quantitative RT-PCR. The SENP1 KO 
fetal liver showed a marked decrease in adult forms of hemo-
globin (Hbb-a1 and Hbb-b1) with a dramatic increase in the 
corresponding embryonic forms (Hbb-x and Hbb-y; Fig. 2 F, 
ratios of Hbb-a1/Hbb-x and Hbb-b1/Hbb-y). To determine 
the stage of erythroid differentiation at which SENP1 KO 
develop defects, we compared the abilities of fetal liver cells 
derived from WT and SENP1 KO E13.5 embryos to form 
CFU-e and more immature BFU-e. SENP1-deletion had   
no effects on the number of the BFU-e (Fig. 2 G, BFU-e). 
However, the number of CFU-e showed a significant (40%) 
the WT GATA1 levels, die between E13.5 and 14.5 as a result 
of ineffective primitive and definitive erythroid differentiation, 
some are born alive (2% instead of the expected 25%), and a 
small number survive to adulthood.
The function of GATA1 is tightly regulated by interaction 
with transcriptional cofactors as well as by several posttransla-
tional modifications including phosphorylation, acetylation, 
and SUMOylation (Boyes et al., 1998; Cantor and Orkin, 
2002;  Collavin  et  al.,  2004;  Yu  et  al.,  2005;  Hernandez- 
Hernandez et al., 2006; Lamonica et al., 2006; Zhao et al., 
2006). However, the in vivo effects of these modifications on 
GATA1 activity have not been defined. In the present study, 
we show that global deletion of SENP1 in mice (SENP1 KO) 
causes erythropoietic defects in fetal liver. We show that the 
GATA1 activity and its target genes are significantly reduced 
in fetal liver of SENP1 KO mice as a result of accumulation of 
SUMOylated GATA1. Mechanistic studies suggest that SENP1 
directly deSUMOylates GATA1, regulating GATA1 DNA-
binding activity and GATA1-dependent EpoR expression and 
erythropoiesis. Our study provides a novel mechanism by which 
GATA1 activity is modulated during erythropoiesis.
RESULTS
Generation of SENP1 KO mice by homologous 
recombination
We generated SENP1lox/lox mice based on homologous re-
combination. We first generated global deletion of SENP1 by 
mating SENP1+/lox mice with -actin–Cre mice to obtain 
SENP1+/ mice, with deletion of both the targeted region (ex-
ons 5 and 6) and the Neo gene (Fig. 1, A–C). SENP1+/ mice 
appeared normal and fertile. We attempted to generate 
SENP1/ (SENP1 KO) mice by intercrossing SENP1+/, 
and no live SENP1 KO mice were obtained after weaning. We 
then carefully examined mouse genotyping and phenotypes at 
E13.5 and 16.5 of embryonic development and on the day of 
birth (postnatal day [P] 0). Typical genotyping of SENP1+/+ 
(WT), SENP1+/ (heterozygote), and SENP1/ (KO) mice 
are shown in Fig. 1 D. Deletion of SENP1 in SENP1 KO mice 
was verified by RT-PCR using primers amplifying exons 5–6 
and by Western blotting with an anti-SENP1 antibody recog-
nizing the C-terminal domain of SENP1. Neither SENP1 
transcripts encoding for exons 5–6 (not depicted) nor SENP1 
protein was detected in SENP1 KO E13.5 fetal liver (Fig. 1 E). 
The ratios of live and dead SENP1 KO embryos were analyzed 
(Fig. 1 F). Only three SENP1 KO littermates among 384 born 
pulps survived to 2 wk of age, and each had severe anemia (un-
published data). We focused on E13.5–16.5 to further charac-
terize the SENP1 KO phenotype.
Erythropoiesis defects in SENP1 KO fetal liver
Starting at E13.5, SENP1 KO embryos and fetal livers were 
paler and smaller than those of WT and heterozygote. Both 
the SENP1 KO embryo and yolk sac have poor blood vessel 
development with fewer red blood cells, indicating anemia in 
SENP1 KO (Fig. 2 A). Erythropoiesis is initiated in the yolk sac 
at around E8.0 during normal mouse development (primitive 
Figure 3.  Erythropoiesis defects in SENP1 KO fetal liver confirmed 
by BMT. (A) Flow cytometry analysis of engraftment ratio in BM of recipi-
ent mice. E13.5 fetal liver cells of WT and SENP KO mice (CD45.2+) were 
injected into irradiated Pep3B recipients (CD45.1+). Data are mean ± SEM 
from six mice per group. (B) Flow cytometry analysis in BM of recipient 
mice. Erythroid cells (TER119+) and granulocytes (Gr1+) were quantified by 
FACS with respective antibodies. The percentage of each cell type in 
CD45.2+ population from six mice is shown. Data are mean ± SEM from  
six mice per group. *, P < 0.01. (C) CBC analysis from peripheral blood of 
recipient mice. Hemoglobin concentration, numbers of red blood cells, 
lymphocytes, and monocytes are shown. Data are mean ± SEM from six 
mice per group. *, P < 0.01. Similar results were observed in additional two 
independent experiments with the same number of mice in each group.JEM VOL. 207, June 7, 2010 
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difference was detected between WT and SENP1 KO fetal 
liver cells in the reconstitution of recipient BM (Fig. 3 A, per-
centage of CD45.2+ cells). We confirmed the genotype of the 
donated fetal liver cells 6 mo after BM transplantation (BMT) 
by genotyping blood samples with WT or SENP1 KO–spe-
cific primers (unpublished data). We then measured precursor 
cells in BM of recipient mice by flow cytometry with specific 
antibodies. Erythroid cells (TER-119+/CD45.2+ ratio) were 
significantly decreased in mice receiving KO versus WT fetal 
liver cells, whereas there was no significant difference in gran-
ulocyte maturation for KO versus WT donors (Gr-1+CD45.2+ 
ratio; Fig. 3 B). We also performed complete blood counts 
(CBCs) of the peripheral blood from WT, WT BMT, and KO 
BMT groups. Consistent with the decreased number of ery-
throid cells (TER-119+) and megakaryocytes (CD41+) in their 
BM, SENP1 KO recipients showed decreases in hemoglobin, 
hematocrit, and number of red blood cell compared with the 
recipients of WT cells. However, lymphocytes and monocytes 
were increased (Fig. 3 C). These results suggest that SENP1 
decrease in SENP1 KO fetal liver cells (Fig. 2 G, CFU-e). 
Similar reduction in megakaryocyte CFU (CFU-mk), the 
closest  differentiation  pathway  with  erythropoiesis,  was   
observed in SENP1 KO (Fig. 2 G, CFU-mk). In contrast, 
granulocyte/monocyte CFU (CFU-G/M) was not signifi-
cantly altered (Fig. 2 G, CFU-G/M). Interestingly, SENP1 
KO showed an increase in CFU-G concomitant with an in-
crease in CFU-M (Fig. 2 G, CFU-G and CFU-M). This in 
vitro observation is consistent with the in vivo results that 
monocytes in SENP1 KO transplanted recipient mice are in-
creased compared with WT mice (Fig. 3 C).
Transplantation of SENP1 KO fetal liver cells into adult 
recipient BM confers erythropoiesis defects
To further determine if SENP1 KO erythroid progenitor cells 
exhibit an intrinsic defect in erythropoiesis, we measured eryth-
ropoietic activity of fetal liver cells from WT and SENP1 KO 
after transplantation into myeloablated adult WT mice. To this 
end, E13.5 fetal liver cells of WT or SENP KO mice (CD45.2+) 
were  respectively  injected  into  irradiated  Pep3B  recipients 
(CD45.1+). The engraftment ratio in BM of recipient mice af-
ter fetal liver transplantation was analyzed by flow cytometry 
analysis using CD45.2 and CD45.1 surface marker after 6 mo. 
The results suggest that engraftment could reach >95%, and no 
Figure 4.  Decreased GATA1 activity and GATA1-
responsive genes in SENP1 KO fetal liver and stage-
matched hematopoietic progenitors. (A) Expression of 
GATA1, GATA2, and EpoR was examined in E13.5 fetal 
liver of WT and SENP1 KO mice by Western blotting with 
respective antibodies. The relative protein levels were 
quantified by taking normalized WT (vs. tubulin) as 1.0. 
Five other embryos of WT or KO exhibited similar results. 
(B) GATA1 activity in SENP1 KO fetal liver. Nuclear  
extracts were isolated from E13.5 WT and SENP1 KO fetal 
livers (n = 3 each group), and an equal amount of GATA1 
proteins from WT and KO were used for the GATA1 DNA 
binding activity assay by EMSA with a GATA1-specific 
oligonucleotide probe. A nuclear protein USF2 was used 
as a loading control. A representative gel from three 
independent experiments is shown. The relative GATA1 
DNA-binding activity and protein levels were quantified 
by taking WT as 1.0. (C) Representative flow cytometric 
analysis of erythroid differentiation in vivo. Freshly iso-
lated E13.5 WT or SENP1 KO fetal liver cells were doubly 
stained with anti–CD71-PE and anti–Ter119-APC. Flow 
cytometry density plots of all viable fetal liver cells from 
representative WT and SENP1 KO embryo in the same 
littermates are shown. Regions R1–R5 define distinct 
populations of erythroid progenitor cells at different 
stages of differentiation. Primitive progenitor cells (includ-
ing mature BFU-Es and CFU-Es) and proerythroblasts are 
shown in R1, proerythroblasts and early basophilic erythro-
blasts in R2, early and late basophilic erythroblasts in R3, 
chromatophilic and orthochromatophilic erythroblasts in 
R4, and late orthochromatophilic and reticulocytes in R5. 
Numbers represent the percentage of cells within that  
region. Two independent experiments are performed.  
(D) Transcripts for EpoR, Hbb-y, c-Myb, and c-Kit from 
sorted fetal liver cells from R2 areas were quantified by 
quantitative RT-PCR and normalized to -actin. Data are 
mean ± SEM (n = 5 from each group) from two indepen-
dent experiments. *, P < 0.01 versus WT group.1188 DeSUMOylation of GATA1 drives erythropoiesis | Yu et al.
We  first  examined  GATA1  expression  in  these  stage-
matched erythroid cells. WT and SENP1 KO showed no 
differences in GATA1 transcripts (stage R1–R3) and protein 
expression (stage R2–R3; Fig. S3). We then compared GATA1-
responsive genes in the R1 and R2 populations isolated from 
WT and SENP1 KO mice by quantitative RT-PCR. Tran-
scripts for GATA1-inducible genes EpoR and Hbb-y (an 
embryonic hemoglobin expressed in R1 and R2 popula-
tions)  were  decreased  in  SENP1  KO  cells.  In  contrast, 
GATA1-repressive genes, such as c-Myb and c-Kit, were 
up-regulated in SENP1 KO cells (Fig. 4 D, data from R2 
populations). Similar patterns of gene expression were ob-
tained from R1 populations but not in more mature R3 
populations  (unpublished  data).  These  data  suggest  that 
GATA1 activity and its dependent gene expression were re-
duced in SENP1 KO erythroid progenitors, causing a defect 
in erythropoietic maturation and subsequent decrease in to-
tal number of erythroid cells observed in fetal liver. Decrease 
of GATA1 expression observed in SENP1 KO fetal liver 
(Fig. 4 A) is a result of a smaller number of total erythroid 
cells (Fig. 2, C–E).
SENP1 directly regulates GATA-1 SUMOylation
SENP1 is an endopeptidase that removes SUMO from con-
jugated protein targets. We reasoned that deletion of SENP1 
leads to GATA1 SUMOylation, reducing GATA1 activity. 
To test our hypothesis, we first examined if a SUMOylated 
form of GATA1 could be detected in SENP1 KO fetal liver 
in the presence of deSUMOylase inhibitor. The SUMOylated 
form of GATA1 was dramatically increased in SENP1 KO 
fetal liver, which was confirmed by immunoprecipitation with 
anti-SUMO followed by Western blotting with anti-GATA1 
(Fig. 5 A). To determine if SENP1 directly deSUMOylates 
GATA1,  GATA1  WT,  or  a  SUMO-defective  mutant, 
GATA1-K137R was coexpressed with SENP1 WT or a cat-
alytic inactive form with a C603A mutation (SENP1 CA). As 
expected, SUMOylated GATA1 could be detected for GATA1 
WT but not for the GATA1-K137R mutant. Importantly,   
SUMOylated GATA1 was diminished by SENP1 WT. In con-
trast, SENP1 CA increased SUMOylated GATA1 (Fig. 5 B),   
KO fetal liver transplantation confers an anemic phenotype. It 
is of note that the effects of SENP1 deletion on transplanted 
mice were less than those of fetal liver, suggesting a potential 
compensatory event in recipient mice. Indeed, we observed 
enlarged spleens and extramedullary hematopoiesis with in-
creased erythroid precursor clumps, megakaryocytes and 
other  developing  myeloid  populations  in  the  SENP1  KO 
transplanted mice (Fig. S1).
Decreased GATA1 activity in SENP1 KO fetal liver  
and erythroid progenitors
To analyze the molecular determinants of the SENP1 KO 
erythropoietic phenotype, we examined protein expression 
of several critical factors regulating erythropoiesis. Consistent 
with previously published results (Cheng et al., 2007), pro-
tein expression of Epo and its upstream regulator HIF1 was 
reduced in SENP1 KO fetal liver (Fig. S2). Notably, eryth-
ropoietic transcriptional factor GATA1 and its downstream 
target erythropoietin receptor (EpoR) were also reduced in 
protein expression (Fig. 4 A). GATA2, a transcriptional fac-
tor involved in primitive erythropoiesis (Tsai et al., 1994), 
was not significantly altered by SENP1 deletion. Further-
more, GATA1 activity in fetal liver was reduced (more than 
threefold) as determined by electrophoretic mobility shift   
assay (EMSA) using equivalent GATA1 protein input from 
fetal liver nuclear extracts (Fig. 4 B).
To examine if reduction of GATA1-responsive gene ex-
pression is not a result of decreased total numbers of erythroid 
cells in SENP1 KO, we isolated stage-matched erythroid cells 
by FACS sorting with anti-CD71 and anti-Ter119. Freshly 
isolated E13.5 WT or SENP1 KO fetal liver cells were doubly 
stained with anti-CD71 and anti-Ter119. Based on these two 
surface markers, the proportion of erythroid progenitors at 
different stages of differentiation, termed R1–R5, can be   
assessed as described previously (Zhang et al., 2003). In SENP1 
KO fetal liver, a twofold increase in number of less mature 
erythroblasts (R1 and R2) and concomitant twofold decrease 
of more mature erythroblasts (R3–R5) were detected (Fig. 4 C), 
which is consistent with increased proerythroblasts in SENP1 
KO fetal liver visualized by May-Giemsa staining (Fig. 2 F). 
Figure 5.  SENP1 regulates GATA1  
SUMOylation. (A) Increased SUMOylated 
GATA1 in E13.5 SENP1 KO fetal liver. WT and 
KO fetal livers were dissected in the presence 
of 1 mM N-ethylmaleimide (deSUMOylase 
inhibitor) and total homogenates were  
subjected to Western blotting with anti-
GATA1. Tubulin was used as a control. The  
SUMOylated form of GATA1 was determined 
by immunoprecipitation with anti-SUMO 
followed by Western blotting with anti-
GATA1. The ratios of SUMO-GATA1/GATA1 
were quantified. Data are representative from three pairs of embryos. (B) SENP1 deSUMOylates GATA1. GATA1 WT or GATA1-K137R was cotransfected 
with SENP1 WT or SENP1 CA in 293T cells as indicated. GATA1 and SENP1 proteins were detected by Western blotting with anti-GATA1 and anti-Flag, 
respectively. GATA1 conjugated with SUMO is indicated. Experiments were repeated three times.JEM VOL. 207, June 7, 2010 
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obtained  for  expression  of  EpoR  and  -hemoglobin  by 
quantitative RT-PCR (unpublished data).
It has been previously reported that erythropoietic defi-
ciency of SENP1 mutant mice is partly a result of inappro-
priate HIF1 activity (Cheng et al., 2007), and we also 
observed  reduction  of  HIF1  expression  in  SENP1  KO   
fetal liver (Fig. S2). We next determined relative contribu-
tions of GATA1 and HIF1, two erythropoietic transcrip-
tion factors regulated by SUMOylation, to SENP1-mediated 
erythropoiesis. To this end, SENP1 CA was coexpressed 
with GATA1 or HIF1 into HEL cells (Fig. S4 A, protein 
expression of the transgenes), and erythropoiesis was mea-
sured for hemoglobin-positive cells by benzidine staining. 
Results showed that coexpression of GATA1 or HIF1 
partially,  and  together  additively,  rescued  SENP1  CA– 
induced hematopoietic defects (Fig. 6 c). These data suggest 
that  both  GATA1  and  HIF1  contribute  to  SENP1- 
mediated erythropoiesis.
suggesting that the catalytic inactive form of SENP1 may 
function as a dominant-negative mutant.
Critical role of SENP1-mediated GATA1 deSUMOylation  
in erythropoiesis
To  directly  test  the  role  of  SENP1-mediated  GATA   
SUMOylation in erythropoiesis, we determined effects of 
SENP1 CA on erythropoiesis in a human erythroleukemic 
cell line (HEL), which undergoes erythropoiesis in the pres-
ence of hemin (Martin and Papayannopoulou, 1982). HEL 
cells  were  infected  with  adenovirus  expressing  LacZ  or 
SENP-C603A followed by treatment with hemin for 96 h, 
and  erythropoiesis  was  measured  for  hemoglobin-positive 
cells by benzidine staining. Infection efficiency was >90% as 
measured  by  -galactosidase  staining  (unpublished  data). 
SENP1 CA significantly blocked hemin-induced erythropoi-
esis as indicated by a reduced number of benzidine-positive 
cells (Fig. 6, A and B [quantification]). Similar results were 
Figure 6.  A critical role of SENP1-medi-
ated GATA1 deSUMOylation in erythro-
poiesis. (A and B) Overexpression of a 
catalytic form of SENP1 (C603A) inhibits 
erythropoiesis. Erythroleukemic cell line HEL 
cells were either uninfected or infected with 
adenovirus expressing LacZ or SENP1 CA. Cells 
were treated with hemin (40 µM) for 96 h and 
hemoglobin-positive cells by benzidine stain-
ing (brown cells indicated by arrowheads in 
A). Bars, 20 µM. Quantitative results shown in 
B are mean ± SEM determined from six differ-
ent areas of each group. *, P < 0.01. Similar 
results were obtained from additional four 
experiments. (C) Overexpression of GATA1 or 
HIF1 rescued SENP1 CA–induced defects in 
hematopoiesis. HEL cells were infected with 
adenovirus expressing SENP1 CA in the pres-
ence of GATA1 or HIF1. Erythropoiesis assays 
were performed as in A and B. Quantitative 
results shown in C are mean ± SEM deter-
mined from six different areas of each group. 
*, P < 0.01. Experiments were repeated twice. 
(D–G) Overexpression of SENP1 CA inhibits 
GATA1 recruitment to the EpoR promoter.  
(D) Human EpoR promoter region with GATA1 
binding site at 45 and the transcriptional 
site (TSS). A PCR fragment for ChIP assay cov-
ering 238 to 26 is indicated. Exon 8  
region (+5926 to +6126) was used for a con-
trol. HEL cells were infected with adenovirus 
expressing LacZ or SENP1 CA, followed by 
treatment with hemin for 96 h as described in 
A. (E) Nuclear extract was used for Western 
blotting with anti-GATA1 and anti-Flag (for 
SENP1 CA). Nuclear protein USF2 was used as 
a control. (F) Nuclear extracts were subjected 
to ChIP assay with anti-GATA1 followed by PCR amplification of the EpoR promoter GATA1-binding site and exon 8. An IgG isotype was used as a control. 
Representative ChIP PCR product of the EpoR promoter GATA1 binding site is shown. (G) Quantitative analyses of the PCR products are presented as ratio 
of ChIP/Input, and data are mean ± SEM from three independent experiments. *, P < 0.01.1190 DeSUMOylation of GATA1 drives erythropoiesis | Yu et al.
GATA4 (Wang et al., 2004; Carter et al., 2007). SUMO fusion 
to the N terminus of GATA1 (Fig. 7 A) had no effects on its 
expression or its stability as measured for its half-life in the pres-
ence of protein synthesis inhibitor cycloheximide (Fig. S5 A). 
GATA1 WT K137R with or without SUMO fusion showed 
a similar pattern of nuclear localization (Fig. 7 B; and Fig. S6, 
A and B [quantification]). However, SUMO fusion completely 
diminished the DNA binding activity of GATA1 as measured 
by EMSA using a GATA1 probe (Fig. 7 C).
Critical role of GATA1 SUMOylation in erythropoiesis
Finally, we determined the functional significance of GATA1 
SUMOylation in erythropoiesis. To this end, HEL cells were 
infected with retrovirus encoding GATA1 WT, GATA1-
K137R, SUMO-GATA1, or SUMO-GATA1K137R (Fig. S7 A, 
expression). Erythropoiesis was measured for hemoglobin-
positive cells by benzidine staining as described in Fig. 6, ex-
cept with no hemin treatment. Expression of GATA1 WT, 
induced erythropoiesis, and expression of KR strongly in-
duced erythropoiesis, as indicated by a reduced number of 
benzidine-positive cells. In contrast, SUMO fusion proteins 
(GATA1 WT and KR) failed to induce erythropoiesis (Fig. S7, 
B and C [quantification]).
To eliminate any endogenous GATA1 effects, we re-
constituted various GATA1 forms into G1E cells, a GATA1-
null erythroid precursor cell line defective in erythropoiesis 
(Welch et al., 2004). G1E cells were infected with retrovirus 
encoding GATA1 WT, GATA1-K137R, SUMO-GATA1, 
or SUMO-GATA1K137R. Expression of GATA1 proteins 
was determined by Western blotting (Fig. 8 A). Transcripts 
of GATA1 responsiveness were determined by quantitative 
RT-PCR. Overexpression of GATA1 WT and GATA1-
KR strongly enhanced transcription of the GATA1-induc-
ible  genes  (EpoR  and  -hemoglobin)  but  reduced  the 
Recruitment of GATA1 to the GATA1 site in the EpoR 
promoter  is  critical  for  EpoR  expression  and  subsequent 
erythropoiesis (Zon et al., 1991). To directly determine the 
effects of SENP1 CA on GATA1 activity and EpoR tran-
scription in HEL cells, we measured GATA1 binding to the 
EpoR promoter in SENP1 CA–infected cells by chromatin 
immunoprecipitation (ChIP) assay. HEL cells were infected 
and treated with hemin for 96 h, and nuclei were subjected to 
ChIP with anti-GATA1 followed by a PCR amplification of 
the GATA1 binding site in the EpoR promoter. An isotype 
IgG and a region on exon 8 were used as a negative control   
for immunoprecipitation and PCR amplification, respectively 
(Fig. 6 D). Expression of SENP1 had no effect on the total 
level of GATA1 (Fig. 6 E). However, expression of SENP1 
CA significantly blunted the binding of GATA1 to the EpoR 
promoter region (Fig. 6, F and G [quantification], representa-
tive ChIP gel). These data strongly support a critical role of 
SENP1 in controlling GATA1 recruitment to the EpoR pro-
moter and subsequent erythropoiesis.
GATA1 SUMOylation inhibits its DNA binding
Reduction  of  GATA1  recruitment  to  EpoR  promoter  in 
SENP1 KO cells could be a result of alterations of SUMOylated 
GATA1 in protein stability, nuclear localization, and protein 
and/or DNA-binding activity as demonstrated for other tran-
scriptional factors (Müller et al., 2001; Seeler and Dejean, 2003; 
Gill, 2004), and we next examined if SUMO conjugation   
affects these activities of GATA1. SUMOylation, like other 
posttranslational modification, is a dynamic process. Only a 
small proportion of a given SUMOylated protein can be de-
tected (Fig. 5), and it has been difficult to determine a suppres-
sive effect of SUMO conjugation on a specific protein. To get 
around this issue, we used a SUMO fusion strategy, which has 
been applied to other SUMOylated proteins such as p53 and 
Figure 7.  GATA1 SUMOylation inhibits 
its DNA binding. (A) Schematic diagram for 
GATA1 structural domains and expression 
construct for SUMO-GATA1 fusion protein 
(bottom). The natural SUMOylation site on 
GATA1 (K137) is indicated (top). AD, acidic 
domain; TD, transactivation domain; DBD, 
DNA-binding domain. (B) GATA1 WT, GATA1-
K137R, SUMO-GATA1 WT, and SUMO-GATA1-
KR show a similar punctate staining in the 
nucleus. Localization of GATA1 in BAEC (which 
lacks endogenous GATA1) was determined by 
indirect immunofluorescence microscope with 
anti-GATA1 followed by an FITC-conjugated 
anti–rat secondary antibody. The nucleus was 
counterstained by DAPI (blue). Representative 
images from 20 cells in each group are shown. 
Bars, 5 µM. (C) SUMO-GATA1 reduces the  
DNA binding activity. Various GATA1 con-
structs were transfected into 293T, and nu-
clear extracts were subjected to EMSA using a GATA1-specific oligonucleotide probe (top) and Western blotting with anti-GATA1 (bottom). * indicates a  
SUMOylated form of SUMO-GATA1 and  indicates a potential deconjugated/cleaved GATA1. Similar results were obtained from two additional experiments.JEM VOL. 207, June 7, 2010 
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DISCUSSION
In this paper, we report that we have created SENP1 KO mice 
based on a homologous recombination system. The SENP1 
KO mouse tissues express neither the SENP1 transcript encod-
ing exons 4–5, as verified by RT-PCR, nor the SENP1 pro-
tein, as verified by Western blotting with anti-SENP1 antibody 
recognizing the C-terminal catalytic domain. There have been 
two studies on SENP1 mutant mice, and mice from both these 
studies were derived from ES cell lines with a retroviral vector 
that had been randomly inserted into the enhancer region or 
the coding region of the SENP1 gene, causing inactivation of 
the gene (Yamaguchi et al., 2005; Cheng et al., 2007). Consis-
tent with our SENP1 KO mice, these SENP1 mutant mice 
show severe fetal anemia. Cheng et al. (2007) have also dem-
onstrated that SENP1, via a direct deSUMOylation of HIF1, 
regulates HIF1 stability and HIF1-dependent genes, includ-
ing Epo, causing defects of erythropoiesis. Consistent with this 
GATA1-repressive genes (Myb). In contrast, SUMO con-
jugation of GATA1 diminished GATA1 responsiveness of 
these genes (Fig. 8 B).
To directly determine if diminished GATA1 respon-
siveness of gene expression is the result of a blocked recruit-
ment of SUMO-GATA1 to the GATA1-responsive genes, 
we measured the binding of GATA1 proteins to the EpoR 
and  -hemoglobin  promoters  in  GATA1-infected  G1E 
cells by ChIP assay. The GAPDH gene promoter was used 
as a negative control (Fig. 8 C). Similar to Fig. 6, nuclei 
were subjected to ChIP with anti-GATA1 followed by   
a PCR amplification of the GATA1 binding site in the 
EpoR and -hemoglobin promoters. An isotype IgG was 
used as a negative control for immunoprecipitation. Consis-
tent with the DNA binding activity and the gene induction 
of GATA1 proteins, both GATA1 WT and GATA1-K137R 
bound to the EpoR promoter region, and GATA1-K137R 
was  stronger  than  GATA1  WT  as  expected.  However, 
SUMO-GATA1 failed to be recruited to the EpoR and   
-hemoglobin promoters (a representative ChIP gel from 
the EpoR gene is shown in Fig. 8 D with quantification   
in Fig. 8 E).
Figure 8.  Regulation of erythropoiesis by 
GATA1 SUMOylation. G1E cells were infected 
with retrovirus encoding GATA1 WT, GATA1-
K137R, SUMO-GATA1, or SUMO-GATA1K137R. 
A retrovirus vector (VC) was a control.  
(A) Expression of GATA1 was determined by 
Western blot. * indicates a SUMOylated form of 
SUMO-GATA1. (B) Transcripts for EpoR, Hbb-b1, 
and c-Myb from G1E cells were quantified by 
quantitative RT-PCR and normalized to -actin 
48 h after retroviral infection as indicated. Data 
are mean ± SEM from three independent  
experiments. *, P < 0.01. (C–F) SUMO-GATA1 
fails to be recruited to the EpoR and Hbb-b1 
promoters. The promoter regions with a GATA1 
binding site in mouse EpoR and Hbb-b1 genes 
are shown in C. TSS, the transcriptional site. 
PCR fragments for ChIP assay are indicated.  
A 3 UTR promoter region from the GAPDH 
gene was used for a control. Nuclei were sub-
jected to ChIP assay as described in Fig. 6.  
Representative ChIP PCR products of the 
GATA1-binding site on EpoR promoter are 
shown in D and quantitative analyses of PCR 
products (ratio of ChIP/Input) for the three 
genes are shown in E. Data are mean ± SEM 
from three independent experiments.  
*, P < 0.01 versus VC group. (F) Model  
for a critical role of SENP1 in regulation of 
GATA1 and GATA1-dependent erythropoiesis. 
GATA1 is synthesized and SUMOylated by an 
unknown SUMO ligase to retain in an inactive 
state. Upon erythropoietic stimuli, deSUMOylated 
GATA1 binds to the GATA1 sites within a 
gene promoter, inducing expression of  
GATA1-dependent erythropoiesis genes in-
cluding EpoR, hemoglobin, and GATA1 itself. 
SENP1 KO mice show enhanced GATA1  
SUMOylation, which blocks the GATA1 DNA-
binding activity and subsequent associations 
with the promoters of erythropoietic genes, 
leading to erythropoiesis defects and anemia.1192 DeSUMOylation of GATA1 drives erythropoiesis | Yu et al.
studied. GATA1 can be strongly phosphorylated at residue 
Ser26 of the N-terminal acidic activation domain by MAPK 
and  at  Ser310  of  the  DNA-binding  domain  by  Akt  in   
response to growth factors such as Epo (Yu et al., 2005; 
Zhao et al., 2006). Phosphorylation of GATA1 increases 
GATA-1–mediated transcription without significantly chang-
ing the DNA-binding affinity of GATA1. However, GATA1 
acetylation by cofactor p300 enhances its DNA-binding 
and recruitment to chromatin (Boyes et al., 1998; Hernandez-
Hernandez et al., 2006; Lamonica et al., 2006). In contrast, 
the role of SUMOylation of GATA1 has not been well de-
fined. GATA1 SUMOylation was initially identified based 
on its interaction with the SUMO E3 ligase PIASy (Collavin   
et al., 2004). Given the fact that only a small proportion 
(<5%) of GATA1 can be SUMOylated in cells, an inhibi-
tory effect of SUMOylation on GATA1 cannot be readily 
detected. We have taken three different approaches to ad-
dress this issue. First, we delete the SUMO endopeptidase 
SENP1 or express a dominant-negative form of SENP1 to 
promote GATA1 SUMOylation. This enhanced GATA1 
SUMOylation dramatically represses the DNA binding and 
the transcriptional activities of GATA1 in erythropoiesis. 
Second, we use GATA1-null cells to show that a non- 
SUMOytable GATA1 mutant (K137R) has a higher activ-
ity  than  GATA1  in  DNA-binding  and  induction  of 
erythropoiesis. Finally, we demonstrate that SUMOylated 
GATA1,  in  a  GATA1-SUMO  fusion  form,  blunts  the 
DNA-binding activity and subsequent recruitment to the 
EpoR and -hemoglobin gene promoters and erythropoi-
esis. Collectively, we conclude that GATA1 SUMOylation 
inhibits its DNA-binding and erythropoietic activity.
Our study is the first demonstration of a functional signif-
icance of GATA1 SUMOylation. The exact mechanism by 
which SUMO modification inhibits GATA1 DNA binding 
and the subsequent recruitment to chromatin is currently un-
clear. It is conceivable that SUMOylation of GATA1, which 
is the opposite of acetylation, alters GATA1 conformation in 
a way that is unfavorable for DNA interaction. Whether   
or not SUMOylation of GATA1 in cells prevents GATA1 
acetylation or its interactions with other coactivators are   
under investigation.
MATERIALS AND METHODS
Targeted inactivation of SENP1 gene by homologous recombina-
tion. The SENP1 targeting arms were isolated from BAC clone identified 
by screening a Research Genetics (Invitrogen) BAC library using SENP1 
cDNA as a probe. The targeting vector was constructed in a pEASY-flox 
backbone to contain a loxP site inserted upstream of SENP1 exon 5 and a 
neomycin cassette (Neo) flanked by two loxP sites down stream of exon 6 
using standard molecular procedures. The linearized targeting construct was 
electroporated into 129/C57B/6 ES cells, and the targeted clones were se-
lected with G418 and gancyclovir. Resistant clones were screened for ho-
mologous recombination by PCR and confirmed by Southern blot analysis. 
Two independent SENP1lox ES cell clones were injected into C57BL/6 
blastocysts. Chimeras were further bred with C57BL/6 female for germline 
transmission. SENP1lox/lox mice were mated with -actin–Cre mice to me-
diate a recombination in vivo resulting in a complete deletion of SENP1 
exon 5 and exon 6 and a frameshift of the downstream catalytic domain.
finding, we also observed that HIF-1 protein and Epo gene 
expression were reduced in our SENP1 KO mice and that over-
expression of HIF1 could partially rescue a hematopoiesis   
defect induced by SENP1 deletion. Importantly, we have found 
that GATA1 is another important target of SENP1 during   
hematopoiesis (Fig. 8 F).
The evidence for the role of SENP1 in regulation of 
GATA1 activity is compelling. The quantitative RT-PCR 
analysis for mRNA, Western blotting for protein expression, 
and EMSA for the DNA binding activity clearly show that 
the GATA1 activity is down-regulated in fetal liver of the 
SENP1 KO mice. We found that a SUMOylated form of 
GATA1 is accumulated in SENP1 KO mice, correlating 
with down-regulation of GATA1-dependent genes includ-
ing EpoR and -hemoglobin. We further show that SENP1 
can directly deSUMOylate GATA1, modulating GATA1-
dependent EpoR expression and erythropoiesis by in vitro 
assays.  Gene-targeting  and  loss-of-function  studies  have 
proved that GATA1 plays an essential role in erythropoiesis 
and megakaryopoiesis (Yamamoto et al., 1990; Weiss and 
Orkin, 1995). Indeed, SENP1 KO mice show defects in 
both processes in fetal liver and in the BM with transplanted 
fetal  liver  cells.  We  observed  increased  lymphocytes  and 
monocytes in SENP1 KO fetal liver–transplanted recipient. 
This is consistent with the data that GATA1 deficiency could 
enhance multipotential differentiation ability of erythroid-
committed cells (Kitajima et al., 2006). SENP1 KO mice 
show a milder anemia phenotype than GATA1-deficient mice, 
which die at E10.5 as a result of severe anemia with arrest of 
erythroid maturation. This is expected because GATA1 in 
SENP1 KO cells are not entirely SUMOylated. Therefore, 
GATA1 activity and GATA1-dependent gene expression is 
reduced, but not completely eliminated, in SENP1 KO. 
Therefore, SENP1 KO mice show a similar phenotype to 
GATA1 knockdown (GATA1.05 and GATA1-low mice, 
which express only 5–20% of the WT GATA1 levels, re-
spectively; McDevitt et al., 1997; Takahashi et al., 1997). 
GATA1 SUMOylation is balanced by SUMO ligases and 
SENPs. Further investigations are needed to identify the 
SUMO ligases responsible for GATA1 SUMOylation and 
the efficiency of the ligase on GATA1. There are six members 
of the SENP family (SENP1–3 and SENP5–7), and each 
SENP has different cellular locations and, likely, has different 
substrate specificities (Gong et al., 2000; Kim et al., 2000; 
Nishida et al., 2000; Best et al., 2002; Hang and Dasso, 2002; 
Kadoya et al., 2002; Zhang et al., 2002; Bailey and O’Hare, 
2004).  Whether  or  not  other  SENPs  members  could   
deSUMOylate GATA1 during erythropoiesis still needs to 
be determined.
The function of GATA1 can be regulated by an array of 
posttranslational modifications, including phosphorylation 
and acetylation as well as SUMOylation (Boyes et al., 1998; 
Cantor and Orkin, 2002; Collavin et al., 2004; Yu et al., 
2005; Hernandez-Hernandez et al., 2006; Lamonica et al., 
2006; Zhao et al., 2006). Phosphorylation of GATA1 and its 
role in regulation of GATA1 function has been extensively JEM VOL. 207, June 7, 2010 
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adenovirus stock was a gift from F. Giordano (Yale University). All adenovi-
rus was amplified in 293T cells and purified by ultracentrifugation. HEL cells 
were infected with adenovirus at MOI of 100 for 48–72 h before subsequent 
assays. Retroviral vector pMY.IRES.EGFP and ecotropic packaging cell line 
PLAT-E were gifts from T. Kitamura (Tokyo University, Tokyo, Japan). 
GATA-1 WT, GATA1-K137R, Sumo-GATA1 WT, and Sumo-GATA1-
K137R cDNAs were inserted into the multicloning site of pMY.IRES.
EGFP. The retrovirus supernatant was obtained by a transient transfection of 
the retroviral vectors to the PLAT-E packaging cell line using Lipofectamine 
2000 (Invitrogen). 106 G1E cells were resuspended in 2 ml retrovirus super-
natant with 1 µg polybrene per ml and the infection was done by spinocula-
tion (2 h, 25°C, 2,500 rpm).
Cell culture of G1E and HEL cells. GATA1-null G1E cell was a gift 
from M.J. Weiss, (University of Pennsylvania School of Medicine, Philadel-
phia, PA) and was cultured in IMDM supplemented with 15% fetal calf   
serum,  1:10,000  monothioglycerol  (Sigma-Aldrich),  human  recombinant 
erythropoietin (R&D Systems) at 2 U/ml, and kit ligand (PeproTech) at   
50 ng/ml and penicillin/streptomycin at 37°C in 5% CO2 in a humidified 
incubator as previously described (Weiss and Orkin, 1995). HEL cells were 
cultured in RPMI 1640 medium (Invitrogen) supplemented with 10% fetal 
calf serum, 2 mM L-glutamine, and penicillin/streptomycin at 37°C in 5% 
CO2 in a humidified incubator. To induce differentiation, 2 × 105 cells per 
ml were cultured in the presence of 40 µM hemin (Sigma-Aldrich) for 3 d 
or as specified.
Immunoprecipitation and immunoblotting. Cell lysis, protein prepara-
tion, and immunoblotting were performed as described previously (Li et al., 
2008). For detection of SUMOylated proteins, 1 mM N-ethylmaleimide 
(deSUMOylase inhibitor) was added to cell lysates. Antibodies against anti-
SENP1, GATA1, GATA2, EpoR, USF-2, and tubulin were obtained from 
Santa Cruz Biotechnology, Inc., anti-HIF1 was obtained from Novus Bio-
logicals, and anti–Flag-POD was obtained from Sigma-Aldrich.
EMSA and ChIP assay. The double-stranded oligonucleotide containing 
a GATA consensus site from the EpoR gene promoter was used for EMSA. 
Preparation of nuclear extracts and EMSA were performed as previously de-
scribed (Zhang et al., 1995). The ChIP assay was performed exactly as previ-
ously described (Letting et al., 2004; Ji et al., 2008) and analyzed by real-time 
PCR.  All  the  primers  are  listed  in Table  S1.  Antibodies  included  anti-
GATA1 (ab1963; Abcam), a positive control (anti-RNA polymerase II), and 
a negative control (normal IgG).
Gene expression analysis. Total RNA of fetal liver was isolated by using 
phenol/chloroform and isolated using RNeasy kit with DNase I digestion 
(QIAGEN). Reverse transcription was done by standard procedure (Super 
Script First-Strand Synthesis System; Invitrogen) using 1 µg of total RNA. 
Quantitative real-time PCR was performed by using iQ SYBR Green   
Supermix on iCycler Real-Time Detection system (Bio-Rad Laboratories). 
Specific primers for mouse GATA1, GATA2, EpoR, Epo, c-Myb, c-Kit, and 
various isoforms of hemoglobin genes were used. 18 S ribosomal RNA or  actin 
was used as internal control. All the primers are listed in Table S1. The relative 
amount of mRNA normalized with control group as indicated was quantified.
Indirect immunofluorescence confocal microscopy. Fixation, permea-
bilization, and staining of cultured BAEC were performed as described previ-
ously (Li et al., 2008). Alexa Fluor 488 (green)–conjugated secondary antibodies 
(Invitrogen) were used. Confocal immunofluorescence microscopy was per-
formed using a confocal microscope (TCS SP5; Leica), and the acquired im-
ages were transferred to Photoshop 6.0 (Adobe) to generate the final figures.
Statistical analysis. All data are expressed as means ± SEM. Statistical sig-
nificance of differences between different conditions was performed using 
Prism (GraphPad Software, Inc.) with a two-tailed unpaired Student’s t test. 
A value of P < 0.01 was considered as statistically significant.
Histology and immunohistochemistry. Embryos or fetal tissues were 
fixed for immunohistochemical and hematoxylin/eosin staining in 4% para-
formaldehyde. For histological analysis, tissues were embedded in paraffin, 
cut into 5-µM sections, and stained with routine hematoxylin/eosin. For 
immunohistochemical staining, tissue sections were stained with certain   
antibodies (e.g., anti-GATA1 and anti-EpoR) as described previously (He   
et al., 2006; Zhang et al., 2008). Bound primary antibodies were detected 
using avidin-biotin-peroxidase (NovaRed peroxidase substrate kit; Vector 
Laboratories). Pictures from four random areas of each section and five sec-
tions per mouse were taken using a digital camera (Kodak) mounted on a 
light microscope (Carl Zeiss, Inc.). Images were quantified using the Matlab 
software (The Math Works, Inc.) as described previously (He et al., 2006; 
Zhang et al., 2008).
Colony formation assay. Cells were prepared from murine E13.5 fetal   
livers. After lysis of mature red blood cells by PharmLyse (BD), cells were mixed 
with MethoCult M3334 to detect BFU-e or MethoCult M3434 to detect 
CFU-e, CFU-G, CFU-G, and CFU-G/M assays (STEMCELL Technolo-
gies Inc.). Cells were plated in 35-mm dishes and cultured at 37°C with 5% 
CO2 for 3–8 d. For the CFU-e assay, benzidine-positive CFU-e colonies 
were scored on day 3. For BFU-e assay, benzidine-positive BFU-e colonies 
were scored on day 8. For MegaCult-C assays, fetal liver cells were used ac-
cording to the manufacturer’s protocols (STEMCELL Technologies Inc.).   
50 ng/ml human thrombopoietin, 50 ng/ml human IL-11, 10 ng/ml murine 
IL-3, and 20 ng/ml human IL-6 (PeproTech) were used in these assays. The 
cultures were incubated at 37°C with 5% CO2 for 6–8 d. Colonies containing 
more than three megakaryocytes (AchE+ cells) were considered CFU-MKs 
(Cheng et al., 2009). Duplicate assays were performed for each mouse.
BMT of fetal liver cells. BMT was performed in lethally irradiated mice 
(irradiation 2× 5.5 Gy within 3 h) with WT or SENP1 KO fetal liver cells. 
Fetal liver cells were first isolated from E13.5 embryos of WT or SENP1 KO 
mice (CD45.2+), and red cells were removed by PharmLyse and subsequent 
washing with PBS. Cells were counted and 105 cells were injected into the 
tail vein of the Pep3B recipient (CD45.1+). Successful BMT was controlled 
by FACS analysis of peripheral blood with anti-CD45.1 and anti-CD45.2 
antibodies or by genotyping of SENP1 gene 6 wk after BMT. The mice 
were then subjected to FACS analysis for specific cell markers or CBC analysis. 
All animal studies were approved by the institutional animal care and use 
committees of Yale University.
Flow cytometric analysis of specific cell surface markers. To analyze 
erythrocytes, megakaryocytes, and other cell types, the fetal liver cells or   
BM cells were stained with standard protocols using PE-Ter119, PE-Gr1, 
PE-CD41a, PE-CD71, or APC-Ter119 (BD). FACS analysis was performed 
with an LSRII flow cytometer (BD) and FlowJo software (Tree Star, Inc.). 
Isotype controls were used in each experiment.
Murine peripheral blood counts. Mice were anesthetized with Methoxy-
flurane (Medical Developments International) followed by retroorbital bleeding 
(100 µl) using EDTA-treated glass capillary tubes. The blood was evacuated 
into tubes with 5 µl of 0.2M EDTA to prevent clot formation. The CBC   
of blood sample was performed using a Hemavet 950FS (Drew Scientific) 
according to the manufacturer’s protocol.
Plasmids, adenovirus and retrovirus. Mammalian expression plasmids 
for SENP1 WT were described previously (Li et al., 2008). Expression plas-
mid for SENP1-K137R was a gift from E. Yeh (The University of Texas 
M.D. Anderson Cancer Center, Houston, TX). Expression plasmids GATA1 
and K137R mutant were gifts from C. Santoro (Università del Piemonte 
Orientale, Novara, Italy). Expression plasmid for EpoR (B. Forget, Yale Uni-
versity, New Haven, CT) SUMO-GATA1 fusion plasmid was constructed 
by cloning GATA1 into pSUMOstar vector (LifeSensors). Adenoviral vectors 
expressing flag-tagged SENP1-C603A (pAd-SENP1CA) and pAd-GATA1 
was constructed as we described for pAd-AIP1 (Zhang et al., 2008). HIF1 1194 DeSUMOylation of GATA1 drives erythropoiesis | Yu et al.
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